CAVALLI, GIULIO
 Distribuzione geografica
Continente #
EU - Europa 63
NA - Nord America 9
AS - Asia 2
Totale 74
Nazione #
IT - Italia 51
FR - Francia 9
US - Stati Uniti d'America 8
CA - Canada 1
CN - Cina 1
DE - Germania 1
FI - Finlandia 1
IE - Irlanda 1
IN - India 1
Totale 74
Città #
Milan 47
Ashburn 3
Iseo 2
Los Angeles 2
Paris 2
Ancona 1
Campodolcino 1
Columbus 1
Dublin 1
Helsinki 1
London 1
New York 1
Nuremberg 1
Pune 1
Seattle 1
Shanghai 1
Totale 67
Nome #
Anakinra for patients with COVID-19: an updated systematic review and meta-analysis, file eefbd187-2ab9-47b2-8d30-a04246eaba7c 9
ROLE OF TRAINED IMMUNITY AND IMMUNOMETABOLISM IN THE PATHOGENESIS OF ERDHEIM-CHESTER DISEASE, file 68590af8-d226-4ff4-bcaf-ec7a8eb3a5ff 6
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9), file 83f9bf70-48cf-426d-a55f-53805325bf2e 6
The right place for IL-1 inhibition in COVID-19, file b53be75d-fd00-47af-a247-e5061a23da1b 6
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation, file ac99905d-c527-475f-a723-7ca29e2989c8 4
Testosterone in males with COVID-19: A twelve-month cohort study, file ddc59148-d2ca-40d7-ade6-5831c5226657 4
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey, file d68e35f8-bbd8-46d5-8a55-06a947c8a3ea 3
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease, file e0c35a4b-e5bc-5883-e053-d805fe0ac580 3
A bitter effect: thrombocytopenia induced by a quinidine-containing beverage, file e0c35a4b-f8d9-5883-e053-d805fe0ac580 2
Tocilizumab in patients with multisystem Erdheim–Chester disease, file e0c35a4c-12b3-5883-e053-d805fe0ac580 2
Treating Pulmonary Silicosis by Blocking Interleukin 1, file e0c35a4c-973f-5883-e053-d805fe0ac580 2
BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease., file e0c35a4c-9745-5883-e053-d805fe0ac580 2
Interleukin-6 in ANCA-associated vasculitis: Rationale for successful treatment with tocilizumab, file e0c35a4b-d9aa-5883-e053-d805fe0ac580 1
Methotrexate in refractory bilateral juvenile temporal arteritis: Report of a case, file e0c35a4b-db0d-5883-e053-d805fe0ac580 1
Erdheim-Chester disease., file e0c35a4b-e2b0-5883-e053-d805fe0ac580 1
Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity, file e0c35a4b-eccc-5883-e053-d805fe0ac580 1
Interleukin-1 receptor blockade rescues myocarditis-associated end-stage heart failure, file e0c35a4c-1917-5883-e053-d805fe0ac580 1
Priorities of biomedical research, file e0c35a4c-4246-5883-e053-d805fe0ac580 1
Efficacy and safety of biological agents in adult-onset Still's disease, file e0c35a4c-9741-5883-e053-d805fe0ac580 1
Anakinra therapy for non-cancer inflammatory diseases, file e0c35a4c-990e-5883-e053-d805fe0ac580 1
Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition, file e0c35a4c-9910-5883-e053-d805fe0ac580 1
Prevalence of Takayasu arteritis in young women with acute ischemic heart disease, file e0c35a4c-9912-5883-e053-d805fe0ac580 1
Suppression of inflammation and acquired immunity by IL-37, file e0c35a4c-9914-5883-e053-d805fe0ac580 1
Treating Experimental Arthritis with the Innate Immune Inhibitor IL-37 Reduces Joint and Systemic Inflammation, file e0c35a4c-9917-5883-e053-d805fe0ac580 1
Autophagy and Protein Secretion, file e0c35a4c-9d91-5883-e053-d805fe0ac580 1
Erdheim-Chester disease: An in vivo human model of Mϕ activation at the crossroad between chronic inflammation and cancer, file e0c35a4c-9d93-5883-e053-d805fe0ac580 1
Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout, file e0c35a4c-9d95-5883-e053-d805fe0ac580 1
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience, file e0c35a4c-9d97-5883-e053-d805fe0ac580 1
Treating Life-Threatening Myocarditis by Blocking Interleukin-1, file e0c35a4c-9f60-5883-e053-d805fe0ac580 1
Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies, file e0c35a4c-9f65-5883-e053-d805fe0ac580 1
Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance, file e0c35a4c-a0b7-5883-e053-d805fe0ac580 1
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli, file e0c35a4c-a8c9-5883-e053-d805fe0ac580 1
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19, file e0c35a4c-cb3e-5883-e053-d805fe0ac580 1
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation, file e0c35a4c-e0dc-5883-e053-d805fe0ac580 1
Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series, file e0c35a4c-ed75-5883-e053-d805fe0ac580 1
Immunosuppressive strategies in invasively ventilated ARDS COVID-19 patients, file e0c35a4c-f571-5883-e053-d805fe0ac580 1
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use, file e0c35a4c-f71c-5883-e053-d805fe0ac580 1
Totale 74
Categoria #
all - tutte 239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 239


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202029 0 0 0 0 0 0 0 0 0 0 29 0
2020/20212 0 0 0 0 0 0 0 1 0 0 0 1
2021/20223 0 0 1 0 1 0 0 0 0 0 1 0
2022/20239 0 0 0 0 0 0 1 4 0 0 4 0
2023/202431 0 0 2 6 0 5 1 3 7 6 1 0
Totale 74